HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip E Aylward Selected Research

E 5555

7/2012Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program.
5/2011Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip E Aylward Research Topics

Disease

42Myocardial Infarction
01/2021 - 11/2005
38Acute Coronary Syndrome
01/2020 - 06/2002
33Hemorrhage
10/2018 - 11/2006
25Stroke (Strokes)
01/2018 - 11/2005
9Heart Failure
01/2021 - 08/2004
9Ischemia
03/2017 - 11/2006
8ST Elevation Myocardial Infarction
05/2015 - 05/2008
7Coronary Disease (Coronary Heart Disease)
01/2022 - 05/2014
6Atherosclerotic Plaque (Atheroma)
01/2022 - 05/2014
5Hypertension (High Blood Pressure)
01/2022 - 12/2005
5Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 11/2005
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 07/2010
4Unstable Angina
01/2020 - 05/2011
3Peripheral Arterial Disease
01/2021 - 10/2014
3Ischemic Stroke
01/2020 - 07/2016
3Transient Ischemic Attack
07/2016 - 08/2015
3Thrombosis (Thrombus)
05/2016 - 11/2015
3Intracranial Hemorrhages (Intracranial Hemorrhage)
08/2015 - 01/2012
2Acute Kidney Injury (Acute Renal Failure)
08/2016 - 10/2010
2Inflammation (Inflammations)
04/2016 - 07/2012
2Atrial Fibrillation
12/2013 - 03/2008
2Body Weight (Weight, Body)
08/2013 - 03/2010
2Shock
01/2009 - 05/2008
1Dyslipidemias (Dyslipidemia)
09/2020
1Sudden Death
01/2017
1Neoplasms (Cancer)
01/2017
1Albuminuria
08/2016
1Diabetes Mellitus
07/2016
1Myocardial Ischemia (Ischemic Heart Diseases)
07/2016
1Dyspnea (Shortness of Breath)
07/2016
1Atherosclerosis
04/2016
1Chronic Renal Insufficiency
08/2015
1Chest Pain (Chest Pains)
11/2014
1Non-ST Elevated Myocardial Infarction
09/2014
1Embolism (Embolus)
12/2013
1Infarction (Infarctions)
06/2013
1Inferior Wall Myocardial Infarction
08/2010

Drug/Important Bio-Agent (IBA)

19vorapaxarIBA
01/2018 - 01/2012
16Thrombin Receptors (Thrombin Receptor)IBA
01/2018 - 01/2012
10Clopidogrel (Plavix)FDA Link
10/2018 - 11/2006
10Enoxaparin (Lovenox)FDA LinkGeneric
05/2010 - 11/2005
9Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2016 - 12/2005
7Heparin (Liquaemin)FDA LinkGeneric
10/2010 - 11/2005
6darapladibIBA
01/2022 - 05/2014
6Glycoproteins (Glycoprotein)IBA
01/2018 - 11/2006
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2020 - 06/2002
4Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2004
4Prasugrel HydrochlorideFDA Link
10/2018 - 07/2010
4PAR-1 ReceptorIBA
12/2015 - 07/2014
4bivalirudin (Angiomax)FDA Link
10/2010 - 11/2006
3omega-Chloroacetophenone (Mace)IBA
01/2020 - 08/2016
3TicagrelorIBA
07/2016 - 07/2010
3p38 Mitogen-Activated Protein KinasesIBA
04/2016 - 09/2014
36- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA
04/2016 - 09/2014
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
12/2015 - 07/2010
3Peptide Hydrolases (Proteases)FDA Link
05/2015 - 03/2014
3pexelizumabIBA
03/2011 - 05/2008
2alirocumabIBA
01/2020 - 01/2019
2thienopyridineIBA
03/2017 - 11/2015
2CreatinineIBA
08/2016 - 03/2008
2apixabanIBA
01/2016 - 12/2013
2ThrombinFDA Link
11/2015 - 05/2011
2E 5555IBA
07/2012 - 05/2011
2Hemoglobins (Hemoglobin)IBA
01/2010 - 03/2008
1Triglycerides (Triacylglycerol)IBA
01/2022
1CholesterolIBA
01/2021
1pro-brain natriuretic peptide (1-76)IBA
01/2021
1CSL112IBA
01/2021
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2021
1Lipoprotein(a)IBA
01/2020
1oxidized low density lipoproteinIBA
01/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2017
1Troponin T (Troponin T1)IBA
01/2017
1Cystatin CIBA
01/2017
1C-Reactive ProteinIBA
01/2017
1Growth Differentiation Factor 15IBA
01/2017
1AnticoagulantsIBA
08/2015
1Platelet Membrane Glycoprotein IIbIBA
05/2015
1TroponinIBA
11/2014
1Alanine Transaminase (SGPT)IBA
09/2014
1MetalsIBA
09/2014
1Pharmaceutical PreparationsIBA
09/2014
1EnzymesIBA
05/2014
11-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
05/2014
1Warfarin (Coumadin)FDA LinkGeneric
12/2013
1Proteinase-Activated ReceptorsIBA
06/2013
1Abciximab (ReoPro)FDA Link
07/2010

Therapy/Procedure

26Therapeutics
01/2022 - 06/2002
12Percutaneous Coronary Intervention
01/2018 - 05/2008
9Patient Readmission
03/2017 - 11/2005
7Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2019 - 03/2008
3Stents
05/2016 - 09/2014
3Secondary Prevention
11/2015 - 06/2002
3Thrombolytic Therapy
08/2015 - 01/2009
2Blood Transfusion (Blood Transfusions)
10/2010 - 12/2007
1Drug Therapy (Chemotherapy)
01/2021
1Heart Transplantation (Grafting, Heart)
07/2016
1Contraindications
11/2015
1Drug-Eluting Stents
09/2014
1Treatment Delay
03/2011